Broadwood opposes STAAR Surgical acquisition by Alcon

Go back to Broadwood opposes STAAR Surgical acquisition by Alcon

Broadwood Partners Files Definitive Proxy Statement Soliciting STAAR Surgical Stockholders to Vote “AGAINST” Proposed Acquisition by Alcon

September 24, 2025 8:00 AM UTC

Outlines Its Belief that the Proposed Transaction Is the Product of Bad Timing, a Flawed Process, and Significant Conflicts of Interest

Broadwood Believes the Transaction Delivers Less Value than Alternatives, Including a Properly Run Strategic Alternatives Process or Improved Execution as a Standalone Business

Sends Letter to STAAR Stockholders

NEW YORK--(BUSINESS WIRE)-- Broadwood Partners, L.P. and its affiliates (collectively, Broadwood), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company (STAAR or the Company) (NASDAQ:... More